Table of Contents
<< Previous Issue | Dec 2006 (Vol: 2006, Issue: 78) | Next Issue >> |
- Section: Business Commentaries
-
How 'Good' is Your Deal Sheet?
- Section: Cartoons
-
Venture Capitalist
- Section: Company Profile
-
MolMed SpA
- Section: Deal Trackers
-
Vectibix (panitumumab)
- Section: Distribution & Marketing
-
Bradely Pharmaceuticals Increases Portfolio via BioSante
- Section: Features
-
Tanox Strikes Gold with Genentech Alliance
-
Abbott Takes its Speciality Pharma Pick
-
Are Purely Platform Technology Biotech Companies Playing a Shrinking Market?
-
Therapy Focus: Severe Sepsis and Septic Shock
- Section: General
-
AstraZeneca’s Disposal of the Humira® Royalty Stream to Royalty Pharma
- Section: Licensing
-
Palomar Issues Another Sublicence for Hair-removal Technologies
- Section: Mergers & Acquisitions
-
Sirna acquired by Merck for US$1.1 B
-
3M Divests its Pharmaceutical Business
- Section: Research & Development
-
Wyeth and Ablynx Enter into Collaboration and Licence Agreement